| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Berend Malchow, Alkomiet Hasan, Paolo Fusar-Poli, Andrea Schmitt, Peter Falkai, Thomas Wobroc. Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence. European archives of psychiatry and clinical neuroscience. vol 263. issue 1. 2013-08-12. PMID:22907121. |
we performed a systematic review including structural magnetic resonance imaging studies comparing high-risk and schizophrenia patients with and without cannabis abuse and found inconclusive results. |
2013-08-12 |
2023-08-12 |
human |
| Berend Malchow, Alkomiet Hasan, Paolo Fusar-Poli, Andrea Schmitt, Peter Falkai, Thomas Wobroc. Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence. European archives of psychiatry and clinical neuroscience. vol 263. issue 1. 2013-08-12. PMID:22907121. |
while there is some evidence that chronic cannabis abuse could alter brain morphology in schizophrenia in patients continuing their cannabis consumption, there is no convincing evidence that this alteration takes place before the onset of schizophrenia when looking at first-episode patients. |
2013-08-12 |
2023-08-12 |
human |
| Blanca Gutiérrez, Margarita Rivera, Lourdes Obel, Kathryn McKenney, Rafael Martínez-Leal, Esther Molina, Montse Dolz, Susana Ochoa, Judith Usall, Josep Maria Haro, Miguel Ruiz-Veguilla, Francisco Torres, Jorge Cervill. Variability in the COMT gene and modification of the risk of schizophrenia conferred by cannabis consumption. Revista de psiquiatria y salud mental. vol 2. issue 2. 2013-07-25. PMID:23034243. |
variability in the comt gene and modification of the risk of schizophrenia conferred by cannabis consumption. |
2013-07-25 |
2023-08-12 |
Not clear |
| Blanca Gutiérrez, Margarita Rivera, Lourdes Obel, Kathryn McKenney, Rafael Martínez-Leal, Esther Molina, Montse Dolz, Susana Ochoa, Judith Usall, Josep Maria Haro, Miguel Ruiz-Veguilla, Francisco Torres, Jorge Cervill. Variability in the COMT gene and modification of the risk of schizophrenia conferred by cannabis consumption. Revista de psiquiatria y salud mental. vol 2. issue 2. 2013-07-25. PMID:23034243. |
the risk of schizophrenia conferred by cannabis has recently been proposed to be modulated by the val158met polymorphism (rs4680) at the comt gene. |
2013-07-25 |
2023-08-12 |
Not clear |
| Marie-Odile Kreb. [Cannabis and schizophrenia: what risks?]. La Revue du praticien. vol 63. issue 3. 2013-07-08. PMID:23687755. |
[cannabis and schizophrenia: what risks? |
2013-07-08 |
2023-08-12 |
Not clear |
| Héloïse Delavenne, Frederico D Garcia, Florence Thibau. [Schizophrenia: research perspectives]. La Revue du praticien. vol 63. issue 3. 2013-07-08. PMID:23687763. |
increased incidence of schizophrenia is correlated to perinatal environmental factors, recent immigration, urban life and cannabis. |
2013-07-08 |
2023-08-12 |
Not clear |
| A Eden Evins, Alan I Green, John M Kane, Robin M Murra. Does using marijuana increase the risk for developing schizophrenia? The Journal of clinical psychiatry. vol 74. issue 4. 2013-07-02. PMID:23656852. |
does using marijuana increase the risk for developing schizophrenia? |
2013-07-02 |
2023-08-12 |
Not clear |
| A Eden Evins, Alan I Green, John M Kane, Robin M Murra. Does using marijuana increase the risk for developing schizophrenia? The Journal of clinical psychiatry. vol 74. issue 4. 2013-07-02. PMID:23656852. |
an international panel of experts addresses topics such as risk factors for schizophrenia, the potency and effects of cannabis use on adolescents, the effects of concurrent drug use with cannabis on schizophrenia risk, and current attitudes toward marijuana. |
2013-07-02 |
2023-08-12 |
Not clear |
| O E Onwuameze, K W Nam, E A Epping, T H Wassink, S Ziebell, N C Andreasen, B-C H. MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse. Psychological medicine. vol 43. issue 3. 2013-07-01. PMID:22850347. |
mapk14 and cnr1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse. |
2013-07-01 |
2023-08-12 |
Not clear |
| O E Onwuameze, K W Nam, E A Epping, T H Wassink, S Ziebell, N C Andreasen, B-C H. MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse. Psychological medicine. vol 43. issue 3. 2013-07-01. PMID:22850347. |
we previously reported that marijuana misuse in conjunction with specific cannabinoid receptor 1 (cnr1) genetic variants (rs12720071-g-allele carriers) contributed to white-matter (wm) brain volume deficits in schizophrenia patients. |
2013-07-01 |
2023-08-12 |
Not clear |
| O E Onwuameze, K W Nam, E A Epping, T H Wassink, S Ziebell, N C Andreasen, B-C H. MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse. Psychological medicine. vol 43. issue 3. 2013-07-01. PMID:22850347. |
in this study, we assessed the influence of another cannabinoid-related gene, mitogen-activated protein kinase 14 (mapk14), and potential mapk14-cnr1 gene-gene interactions in conferring brain volume abnormalities among schizophrenia patients with marijuana abuse/dependence. |
2013-07-01 |
2023-08-12 |
Not clear |
| P Andreas Ringen, Ingrid Melle, Akiah O Berg, Ingrid Agartz, Olav Spigset, Carmen Simonsen, Kjetil Sundet, Ole A Andreasse. Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder. Schizophrenia research. vol 143. issue 1. 2013-07-01. PMID:23178107. |
evidence of associations between neurocognitive function and cannabis use in schizophrenia is inconclusive. |
2013-07-01 |
2023-08-12 |
Not clear |
| P Andreas Ringen, Ingrid Melle, Akiah O Berg, Ingrid Agartz, Olav Spigset, Carmen Simonsen, Kjetil Sundet, Ole A Andreasse. Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder. Schizophrenia research. vol 143. issue 1. 2013-07-01. PMID:23178107. |
we investigated the relation between cannabis use, determined by its presence in urine, and neurocognitive functioning in schizophrenia controlling for the potential bias of premorbid functioning. |
2013-07-01 |
2023-08-12 |
Not clear |
| Nadia Solowij, Mark Walterfang, Dan I Lubman, Sarah Whittle, Valentina Lorenzetti, Martin Styner, Dennis Velakoulis, Christos Pantelis, Murat Yüce. Alteration to hippocampal shape in cannabis users with and without schizophrenia. Schizophrenia research. vol 143. issue 1. 2013-07-01. PMID:23201308. |
alteration to hippocampal shape in cannabis users with and without schizophrenia. |
2013-07-01 |
2023-08-12 |
Not clear |
| Nadia Solowij, Mark Walterfang, Dan I Lubman, Sarah Whittle, Valentina Lorenzetti, Martin Styner, Dennis Velakoulis, Christos Pantelis, Murat Yüce. Alteration to hippocampal shape in cannabis users with and without schizophrenia. Schizophrenia research. vol 143. issue 1. 2013-07-01. PMID:23201308. |
abnormalities in hippocampal morphology are characteristic of schizophrenia and have also been reported in chronic cannabis users. |
2013-07-01 |
2023-08-12 |
Not clear |
| Nadia Solowij, Mark Walterfang, Dan I Lubman, Sarah Whittle, Valentina Lorenzetti, Martin Styner, Dennis Velakoulis, Christos Pantelis, Murat Yüce. Alteration to hippocampal shape in cannabis users with and without schizophrenia. Schizophrenia research. vol 143. issue 1. 2013-07-01. PMID:23201308. |
there is a paucity of research investigating potential additive effects of cannabis use on brain pathology associated with schizophrenia. |
2013-07-01 |
2023-08-12 |
Not clear |
| Maria Sabrina Spano, Liana Fattore, Francesca Cadeddu, Walter Fratta, Paola Fadd. Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats. Psychopharmacology. vol 225. issue 3. 2013-06-21. PMID:22903392. |
chronic cannabis use can induce psychotic states that resemble schizophrenia. |
2013-06-21 |
2023-08-12 |
rat |
| Maria Sabrina Spano, Liana Fattore, Francesca Cadeddu, Walter Fratta, Paola Fadd. Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats. Psychopharmacology. vol 225. issue 3. 2013-06-21. PMID:22903392. |
yet, schizophrenic patients often smoke cannabis as a form of self-medication to counter the aversive symptoms of schizophrenia. |
2013-06-21 |
2023-08-12 |
rat |
| Brian D Power, Milan Dragovic, Assen Jablensky, Nikos C Stefani. Does accumulating exposure to illicit drugs bring forward the age at onset in schizophrenia? The Australian and New Zealand journal of psychiatry. vol 47. issue 1. 2013-06-17. PMID:23042939. |
the present study was designed to test the hypothesis that consumption of amphetamine and/or cocaine in addition to cannabis would lead to an earlier age at onset of schizophrenia than that seen for cannabis consumption alone. |
2013-06-17 |
2023-08-12 |
Not clear |
| Michael Kiang, Bruce K Christensen, David L Streiner, Carolyn Roy, Iulia Patriciu, Robert B Zipursk. Association of abnormal semantic processing with delusion-like ideation in frequent cannabis users: an electrophysiological study. Psychopharmacology. vol 225. issue 1. 2013-06-10. PMID:22782461. |
frequent cannabis use is a risk marker for schizophrenia and delusions, but the neurocognitive mechanisms of this relationship remain unclear. |
2013-06-10 |
2023-08-12 |
Not clear |